Identifying the Factors Influencing the Completion of Institutional Detoxification Period Among Patients with Substance Use Disorder in Iraq

Authors

  • Sarah Hazem Muslim Al-Kindy Teaching Hospital, Directorate of Health in Al-Rusafa, Baghdad, Iraq
  • Ali Azeez Al-Jumaili Department of Clinical Pharmacy, College of Pharmacy, University of Baghdad, Baghdad, Iraq https://orcid.org/0000-0003-4691-0280
  • Hadeer Akram Al-Ani Department of Public Health Sciences, School of Medicine, University of California, Davis, CA 95776, USA https://orcid.org/0000-0002-2683-6207

DOI:

https://doi.org/10.54133/ajms.v7i2.1566

Keywords:

Substance Abuse, Detoxification, Iraq, Substance use disorder, Treatment acceptance

Abstract

Background: Substance use disorders (SUD) continue to be the primary cause of disability and early death, affecting the global criminal justice, social care, health, and welfare systems. Objectives: To identify the factors influencing the acceptance of patients with SUD to complete the institutional detoxification period. Methods: This retrospective cohort study reviewed the medical records of the Al-Qanat Center for Social Rehabilitation, Baghdad, Iraq. The extraction chart was conducted from July 18 to August 26, 2024. It included patients who received mental services from SUD treatment programs during 2023. Results: The study included 470 patients with SUD. Most patients (95.5%) were male, with an average age of 26.85 years, 52.7% of them were single, 60.1% had low-income jobs, 61.1% had primary school degrees, and >73.8% completed the treatment during the hospitalization period. Addicted women were significantly less likely to complete the detoxification period compared to men. The addicted patients who were more likely to complete the hospitalization period included those with younger age, longer hospitalization periods, and shorter duration of addiction. Methamphetamine (Crystal) was the most used substance (77.7%) by the admitted patients. Conclusion: The gender disparities in treatment completion of SUD highlight the need for gender-sensitive detoxification centers that account for societal factors and encourage family and community support to improve treatment engagement and outcomes. Developing new centers across the country’s provinces is pivotal to being more accessible for such patients.

Downloads

Download data is not yet available.

References

Blackwood R, Lynskey M, Drummond C. Prevalence and patterns of hospital use for people with frequent alcohol-related hospital admissions, compared to non-alcohol and non-frequent admissions: a cohort study using routine administrative hospital data. Addiction. 2021;116(7):1700-1708. doi: 10.1111/add.15354. DOI: https://doi.org/10.1111/add.15354

Ramadan M, Alharbi A, Ahmad RG, Alkhalaf A, Alhusseini N, Algarni AS, et al. Evaluation of substance use disorder readmission and length of hospital stay in a major rehabilitation center in the Gulf States: A retrospective cohort study. Int J Ment Health Addict. 2022:1-16. doi: 10.1007/s11469-022-00920-z. DOI: https://doi.org/10.1007/s11469-022-00920-z

United Nations Office on Drugs and Crime. [cited 2024 Jun 8]. World Drug Report 2023. Available from: https://www.unodc.org/unodc/en/data-and-analysis/world-drug-report-2023.html

Rostam-Abadi Y, Gholami J, Jobehdar MM, Ardeshir M, Aghaei AM, Olamazadeh S. Drug use, drug use disorders, and treatment services in the Eastern Mediterranean region: A systematic review. Lancet Psychiatr. 2023;10(4):282–295. doi: 10.1016/S2215-0366(22)00435-7. DOI: https://doi.org/10.1016/S2215-0366(22)00435-7

Regional Committee for the Eastern Mediterranean Sixty-sixth session WHO. Regional framework for action to strengthen the public health response to substance use Executive summary. September 2019.

Mikhael EM, Jebur NJ, Jamal MY, Hameed TA. Perception, experience, and practice of Iraqi community pharmacists towards customers with substance use disorder. SAGE Open Med. 2024;12. doi: 10.1177/20503121241275472. DOI: https://doi.org/10.1177/20503121241275472

Aqrawi R, Humphreys K. Responding to rising substance misuse in Iraq. Subst Use Misuse. 2009;44(12):1744-1748. doi: 10.3109/10826080902963415. PMID: 19895304. DOI: https://doi.org/10.3109/10826080902963415

Al-Jumaili AA, Younus MM, Kannan YJA, Nooruldeen ZE, Al-Nuseirat A. Pharmaceutical regulations in Iraq: From medicine approval to postmarketing. Eastern Mediterr Health J. 2021;27(10):1007–1015. doi: 10.26719/emhj.21.025. DOI: https://doi.org/10.26719/emhj.21.025

Chachan NE, Al-Hemiary NJ. Socio-demographic, clinical characteristics and risk factors of crystal meth use in Baghdad/Iraq. Muthanna Med J. 2023;10(1):53–66. doi: 10.52113/1/1/2023-53-66. DOI: https://doi.org/10.52113/1/1/2023-53-66

Mohammed QQ. Perceived stigma and treatment-seeking behavior in individuals with substance use disorder in Baghdad. J Contemp Med Sci. 2016;2(4):153–157. doi: 10.22317/jcms.2016130. DOI: https://doi.org/10.22317/jcms.2016130

Al-Hemiary N, Hashim M, Al-Diwan J, Abdul Razzaq E. Alcohol and drug abuse in post-conflict Iraq. J Fac Med Baghdad. 2015;57(4):290–294. doi: 10.32007/med.1936/jfacmedbagdad.v57i4.7. DOI: https://doi.org/10.32007/med.1936/jfacmedbagdad.v57i4.7

Al-Jumaili AA, Aljuboori SB, Kubba AA, Fathel R, Talab H. Evaluate factors influencing depression in Baghdad: Using deck-depression inventory. Inov Pharm. 2019;10(3):6. doi: 10.24926/iip. v10i3.2036. DOI: https://doi.org/10.24926/iip.v10i3.2036

Kathem SH, Al-Jumaili AA, Noor-Aldeen M, Najah N, Ali Khalid D. Measuring depression and anxiety prevalence among Iraqi healthcare college students using hospital anxiety and depression scale. Pharm Pract (Granada). 2021;19(2):1-8. doi: 10.18549/pharmpract.2021.2.2303. DOI: https://doi.org/10.18549/PharmPract.2021.2.2303

United Nations Office on Drugs and Crime. Drug trafficking dynamics across Iraq and the Middle East: Trends and responses. July 2024; p.p. 1–22.

Jumaah ZS, Al-Jumaili AA. The Perceptions of general population about mental health services in Baghdad, Iraq: A Qualitative study. Iraqi J Pharm Sci. 2023;32:283–290. doi: 10.31351/vol32issSuppl.pp283-290. DOI: https://doi.org/10.31351/vol32issSuppl.pp283-290

MOH. Annual Statistical Report with Kurdistan region. Published online 2022:1-300. Available from: https://moh.gov.iq

Amiri M, Sadeghi Z, Sadeghi E, Khosravi A. Relationship between assertion and aggression with addiction potential: A cross-sectional study in 2019. Osong Public Health Res Perspect. 2020;11(4):231-238. doi: 10.24171/j.phrp.2020.11.4.12. DOI: https://doi.org/10.24171/j.phrp.2020.11.4.12

Das SK. Detoxification of drug and substance abuse. In: Medical Toxicology, IntechOpen. 2021. doi: 10.5772/intechopen.90380. DOI: https://doi.org/10.5772/intechopen.90380

Iraqi Ministry of Health. [cited 2024 Nov 9]. Available from: https://moh.gov.iq/?article=7180&sfnsn=mo

Oakland GB. Determining sample size. Canadian Entomologist. 1953;85(3):108–113. doi: 10.4039/Ent85108-3. DOI: https://doi.org/10.4039/Ent85108-3

Divya G, Athithan S, Jan R. Modeling and stability analysis of substance abuse in women with control policies. Partial Differ Equations Appl Math. 2024;9:100650. doi: 10.1016/j.padiff.2024.100650. DOI: https://doi.org/10.1016/j.padiff.2024.100650

Kiani F, Farsani MA. Qualitative study of risk factors of substance abuse among women. J Soc Behav Commun Health. 2023;7(2):1148–1158. DOI: https://doi.org/10.18502/jsbch.v7i2.14093

Motyka MA, Al-Imam A, Haligowska A, Michalak M. Helping women suffering from drug addiction: needs, barriers, and challenges. Int J Environ Res Public Health. 2022;19(21). doi: 10.3390/ijerph192114039. DOI: https://doi.org/10.3390/ijerph192114039

Vourakis C. Treatment services for women with substance use disorders. J Addict Nurs. 2003;14(1):1-2. doi: 10.1080/10884600390238503. DOI: https://doi.org/10.1080/10884600305368

McCrady BS, Epstein EE, Fokas KF. Treatment interventions for women with alcohol use disorder. Alcohol Res. 2020;40(2). doi: 10.35946/arcr.v40.2.08. DOI: https://doi.org/10.35946/arcr.v40.2.08

Al-Hemiery N, Dabbagh R, Hashim MT, Al-hasnawi S, Abutiheen A, Emad A, et al. Self-reported substance use in Iraq : Findings from the Iraqi national household survey of alcohol and drug use, 2014. Addiction. 2017;112(8):1470-1479. doi: 10.1111/add.13800. DOI: https://doi.org/10.1111/add.13800

Younis MS, Lafta RK. The plight of women in Iraq: Gender disparity, violence, and mental health. Int J Soc Psychiatr. 2021;67(8):977-983. doi: 10.1177/00207640211003602. DOI: https://doi.org/10.1177/00207640211003602

Al-Hasnawi SM, Aqrawi R, Sadik S, Humphreys K. Iraqi psychiatrists’ perceptions of substance use disorders among patients. Psychiatr Serv. 2009;60(6):728. doi :10.1176/ps.2009.60.6.728. DOI: https://doi.org/10.1176/ps.2009.60.6.728

Muzil J, Abdulwahid DA, Abed A. Substance abuse in Iraq, quantifying the picture. J Popul Ther Clin Pharmacol. 2023;30(12). doi: 10.47750/jptcp.2023.30.12.036. DOI: https://doi.org/10.47750/jptcp.2023.30.12.036

Landrum B, Knight DK, Becan JE, Flynn PM. To stay or not to stay: Adolescent client, parent, and counselor perspectives on leaving substance abuse treatment early. J Child Adolesc Subst Abuse. 2015;24(6):344-354. doi: 10.1080/1067828X.2013.844088. DOI: https://doi.org/10.1080/1067828X.2013.844088

Raheimi S, Jalali A, Jalali R. Social support among women undergoing methadone maintenance treatment in Iran. J Addict Nurs. 2018;29(3):179–187. doi: 10.1097/JAN.0000000000000234 . DOI: https://doi.org/10.1097/JAN.0000000000000234

Andersson HW, Steinsbekk A, Walderhaug E, Otterholt E, Nordfjærn T. Predictors of dropout from inpatient substance use treatment: A Prospective cohort study. Subst Abuse. 2018;12. doi: 10.1177/1178221818760551. DOI: https://doi.org/10.1177/1178221818760551

McKellar J, Kelly J, Harris A, Moos R. Pretreatment and during treatment risk factors for dropout among patients with substance use disorders. Addict Behav. 2006;31(3):450-460. doi: 10.1016/j.addbeh.2005.05.024. DOI: https://doi.org/10.1016/j.addbeh.2005.05.024

Rose C. The reach of the trade in captagon beyond the Middle East. European View. 2023;22(2):295-303. doi: 10.1177/17816858231205755. DOI: https://doi.org/10.1177/17816858231205755

Steenkamp C. Captagon and conflict: Drugs and war on the border between Jordan and Syria. Mediterranean Politics. 2024:1-25. doi: 10.1080/13629395.2023.2297121. DOI: https://doi.org/10.1080/13629395.2023.2297121

Al-Imam A, Michalak M. Iraq's meth crisis: Prioritizing research to combat suicidal ideation. Al-Kindy Coll Med J. 2024;20(1):78-79. doi: 10.47723/f2m0tp28. DOI: https://doi.org/10.47723/f2m0tp28

Details of the murder incident of the late pharmacist (Mohammed Hashem Saleh) in Baghdad, Iraq. YouTube. Available from: https://www.youtube.com/watch?v=ZIAjAOLUzHY&rco=1

Robbery and attempted murder... ends with the survival of the owner of Zahra Al-Adhamiya Pharmacy and the arrest of the perpetrators." - YouTube. [cited 2024 Oct 29]. Available from: https://www.youtube.com/watch?v=jMVoZpyNtLE&rco=1

Faisal MS. Confronting the crystal meth epidemic: urgent insights and solutions. Int J Pathol. 2024;22(3):101-102. doi: 10.59736/IJP.22.03.914. DOI: https://doi.org/10.59736/IJP.22.03.914

Abdelhakim AK, Sya AB, Damien GB, Klikpo ETE, Gansou GM, Allabi AC. Diagnostic capabilities of self ‑ reported psychoactive substance use among patients admitted to psychiatric consultations in Benin, West Africa. BMC Psychiatr. 2022;1–8. doi: 10.1186/s12888-022-04394-0. DOI: https://doi.org/10.1186/s12888-022-04394-0

Bharat C, Webb P, Wilkinson Z, McKetin R, Grebely J, Farrell M, et al. Agreement between self‐reported illicit drug use and biological samples: a systematic review and meta‐analysis. Addiction. 2023;118(9):1624-1648. doi: 10.1111/add.16200. DOI: https://doi.org/10.1111/add.16200

Gholami J, Ardeshir M, Rostam-Abadi Y, Baheshmat S, Shadloo B, Rahimi-Movaghar A. self-reported methamphetamine use versus biological testing among treatment-seeking patients. IJ Psychiatr Behav Sci. 2024;18(3):e148330. doi: 10.5812/ijpbs-148330. DOI: https://doi.org/10.5812/ijpbs-148330

Al-Imam A, Santacroce R, Roman-Urrestarazu A, Chilcott R, Bersani G, Martinotti G, et al. Captagon: use and trade in the Middle East. Hum Psychopharmacol. 2017;32(3):1–8. doi: 10.1002/hup.2548. DOI: https://doi.org/10.1002/hup.2548

Additional Files

Published

2024-12-30

How to Cite

Muslim , S. H., Al-Jumaili, A. A., & Al-Ani, H. A. (2024). Identifying the Factors Influencing the Completion of Institutional Detoxification Period Among Patients with Substance Use Disorder in Iraq. Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ), 7(2), 202–208. https://doi.org/10.54133/ajms.v7i2.1566

Issue

Section

Original article

Similar Articles

1 2 3 4 5 6 7 8 9 10 > >> 

You may also start an advanced similarity search for this article.